Skip to content

In the BioHarmony Drug Report Database


Lastacaft (alcaftadine) is a small molecule pharmaceutical. Alcaftadine was first approved as Lastacaft on 2010-07-28. It is used to treat allergic conjunctivitis in the USA. Lastacaft's patent is valid until 2027-12-23 (FDA).
Trade Name Lastacaft
Common Name Alcaftadine
Indication allergic conjunctivitis
Drug Class
Get full access now